Cargando…

Oxaliplatin and Infliximab Combination Synergizes in Inducing Colon Cancer Regression

BACKGROUND: Colon cancer is one of the most common malignant cancers and causes millions of deaths each year. There are still no effective treatments for colon cancer patients who are at advanced stage. Tumor necrosis factor-alpha (TNF-α) might be a good therapy target due to its widely-accepted rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenya, Xu, Jian, Zhao, Jian, Zhang, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319445/
https://www.ncbi.nlm.nih.gov/pubmed/28190020
http://dx.doi.org/10.12659/MSM.901880

Ejemplares similares